The Most Compassionate Care In Sight
Elman Retina Group is a premier private practice devoted exclusively to the medical and surgical treatment of the retina and vitreous, with five state-of-the-art offices conveniently located throughout the Baltimore metropolitan area. Founded by Dr. Michael J. Elman over 30 years ago, the practice is internationally recognized for its commitment to clinical research, compassionate patient care, and advancing the field of retina surgery.
Our team of four fellowship-trained retina specialists brings together expertise in vitreoretinal surgery, uveitis, clinical trials, and the latest diagnostic technologies — including Home OCT and ForeseeHome remote monitoring. As one of the top research sites in the DRCR Retina Network, we have directly contributed to treatment breakthroughs that have transformed the care of diabetic eye disease, macular degeneration, and retinal vein occlusion.
At Elman Retina Group, we treat every patient like family. From your first phone call to every follow-up visit, our entire team is dedicated to making you feel welcomed, informed, and cared for.
Latest announcements, research breakthroughs, and new treatment availability
Dr. Elman and Dr. Schechet were part of a cutting-edge wet AMD research study to validate the usability and visualization performance of the new first-of-its-kind Home OCT system leading to FDA marketing authorization.
Read more →
Michael J. Elman, M.D. presented trial results at the 48th Annual Meeting of the Macula Society.
Dr. Schechet explored the connection between overall health and peak performance as you age on the Open Your Eyes Radio Show with Dr. Kerry Gelb.
Read more →
Elman Retina Group expanded with a new office location in Catonsville to better serve patients in the Baltimore metropolitan area.
Elman Retina Group presented 'Wizard of the Eyes' at the Foundation Fighting Blindness VisionWalk 2024.
Dr. Elman presented results on the Clinical Utility of Home OCT Data in Management of Neovascular Age Related Macular Degeneration at the 47th annual meeting of the Macula Society in Palm Springs, California.
Dr. Elman reached over 7,700 citations, positioning him among the top 5% of researchers on Doximity.
A sub-analysis of the ALOFT study showed how remote monitoring can generate aggregates of large data sets and provide unique insights on the predictive nature of non-exudative ForeseeHome alerts.
Six eyes in six patients with dialysis-associated retinal detachments were successfully repaired with one pneumatic retinopexy procedure.
Read more →Dr. Elman was voted #1 in the Vision Care section of the 2021 Baltimore Jewish Times' "Best of Jewish Baltimore" competition.
Read more →Dr. Schechet and his team published new research regarding macular hole closure with medical treatment.
Read more →Dr. Schechet published research showing high rates of musculoskeletal disorders among practicing ophthalmologists — important for prevention through proper ergonomics.
Read more →A new technology impacting surgical technique, management, and decision-making. Published by Dr. Schechet, Dr. Elman, and colleagues in Retinal Physician.
Dr. Elman visited the world-famous Ophthalmology Department at the University of Paris, Créteil, learning ground-breaking methods for analyzing OCT angiograms to aid in early diagnosis of macular diseases.
Dr. Elman served as moderator at the diabetes session and presented results on visual field changes among eyes with proliferative diabetic retinopathy on behalf of the DRCR Retina Network.
Internationally recognized for clinical excellence
A certified research site contributing to breakthroughs in retinal care
A Natural History Observation and Registry Study of Macular Telangiectasia Type 2. Conducted at Franklin Square with annual phone calls.
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening. Fenofibrate vs placebo with follow-up for 4 years.
Vitreous Proteomics in Eyes with macular holes — recruiting vitreous floaters. Sample taken during surgery.
Randomized Trial Comparing Immediate versus Deferred Surgery for Symptomatic Epiretinal Membranes. Follow-up at 3, 6, 12, 18, 24, and 36 months.
Phase 3 study evaluating intravitreal OPT-302 in combination with Ranibizumab vs Ranibizumab alone in participants with neovascular AMD. 2-year duration.
Proof of concept and dose-finding study of Danicopan in patients with geographic atrophy secondary to AMD.
Evaluation of repeated, in-clinic, self-imaging by DME patients using the Notal Vision Home OCT.
Phase 2 study evaluating the safety and efficacy of OTT166 Ophthalmic Solution in the treatment of diabetic retinopathy.
Phase 2a Study to evaluate the efficacy and safety of CU06-1004 for 12 weeks in patients with diabetic macular edema.
Landmark nationwide trial that revolutionized the treatment of diabetic macular edema. Dr. Elman served as national Study Chairman.
Prompt PRP versus intravitreal Ranibizumab with deferred PRP for proliferative diabetic retinopathy.
Comparative effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for diabetic macular edema.
Treatment for central-involved DME in eyes with very good visual acuity (20/25 or better).
Treatment for patients with severe NPDR — Eylea vs observation to determine if early treatment slows progression to PDR.
Comparison of Age-Related Macular Degeneration Treatment Trials.
Randomized trial of Lutein, Zeaxanthin, and Long-Chain Omega-3 Fatty Acids in Age-Related Macular Degeneration, plus 10-year follow-on study.
Standard Care vs Corticosteroid for Retinal Vein Occlusion 2 — testing whether bevacizumab is non-inferior to aflibercept for macular edema due to CRVO.
Patients with non-infectious uveitis and macular edema randomized to triamcinolone vs sham suprachoroidal injections.
Phase III study comparing intravitreal APL-2 therapy with sham injections in patients with geographic atrophy secondary to AMD.
Phase 3 study to determine the safety and efficacy of NT-501 in Macular Telangiectasia Type 2.
Phase 2 trial comparing Lucentis vs study drug for diabetic macular edema.
NIH-supported trial establishing the superior role of Notal's ForeseeHome Monitoring System in preserving vision for eyes at risk of neovascular AMD.
Real experiences from patients whose lives were changed
“From the first moments as a prospective patient of Dr. Michael Elman, I felt the professionalism, caring, kindness, commitment and dedication to healing and research of all at Elman Retina Group. Dr. Elman enrolled me in a DRCR clinical trial, and I have been receiving study-related treatments to my eyes ever since. I was chosen as the national study participation spokesperson and the Maryland state representative for The Special Diabetes Programs Stories of Hope and Progress. NOW I HAVE 20/20 VISION IN BOTH EYES — A SPECTACULAR IMPROVEMENT. As a result of this study, I can say, "I ONCE WAS BLIND BUT NOW I SEE!" I HAVE BEEN BLESSED BY A MIRACLE.
“When I first met Dr. Elman, I was a young and fearless 8th grade student who never thought he would wake up one morning with a detached retina. Dr. Elman quickly became one of the most important people in my life. Being told by other doctors that I should never wrestle again was heartbreaking. Dr. Elman saved my eyesight and gave me the opportunity to continue doing what I love. When I suffered a detached retina in my other eye in college, there was no doubt in my mind I would do anything possible to get home and have the surgery done by Dr. Elman. I now have great vision in both of my eyes and I am still continuing my passion for wrestling. Dr. Elman has truly been a blessing.
“My first retinal tear was almost 20 years ago. Over the holidays, while I was in California, and Dr. Elman was in Israel, I had a complete retinal detachment, which required immediate surgery. Right away, from Israel, Dr. Elman called me and the surgeon in California to begin the process of aftercare. I've heard and seen the way he and his staff talk with their patients, get to know us, and reassure us. This gives me confidence and reduces anxiety. They have a gift for working with seniors calmly, gently, patiently and warmly. We all have the eyes we were born with, but we should all be so lucky as to have the kind of professional and personal care Dr. Elman and his great staff provide.
“When I first started having blurry vision I thought it was a simple problem. After a month of testing, GBMC said it was not that simple. As I was ready to search for help across the country, I was recommended to the Elman Retina Group. Upon my first visit, Dr. Michael Elman calmed my anxiety by immediately identifying my rare case called macular edema. The staff is understanding and supportive at every visit. They are real people who you can get to know and trust with your care. The year long recovery has been slow, but Dr. Elman has been positive and realistic the entire time.
We work hard for our patients — and we celebrate together too
This is how ERG rolls!
Elman Retina Group celebrated Preakness with a DIY hat contest.
The Elman Retina staff celebrating Valentine's Day!
Ugly sweaters, Santa visits at the office, and a pottery painting night at The Pottery Cove!
Fall Harvest board painting at a local craft shop in Cockeys Mill.
We celebrated another year of excellence with our staff!
$47.2K raised for the Foundation Fighting Blindness' 17th annual VisionWalk in Baltimore.
We surprised Dr. Elman at the theater with a video highlighting the last 31 years. Jurassic Park came out the same year the practice started, so we screened it in the theater.
Fitness coaching from Coppermine, a nutritionist, and a wellness coach helped staff learn exercises and stretches for the workplace.
Holiday party at McFadden Art Glass — Secret Santa gift exchange and sponsored a family for Christmas.
This year's theme was 'Musicians' — we did not skip a beat or miss a note with any of our glorious costumes and intricate decorations!
We raised $2,860 and won the award for best team name: 'Wizard of Eyes'.
Dr. Elman presents cutting-edge research with Dr. Schechet and Notal Vision — a validation study for AI-driven home OCT technology.
We LOVE our staff at ERG! We had a blast at a staff appreciation paint night highlighting artistic talent hiding in our midst!
The fashionable Elman Retina Group family celebrates the new year wearing new shirts and wishing everyone 20/20 vision in 2020!
Elman Retina Group celebrated our annual holiday party with a festive and fun bowling party!
Fun times at Elman Retina Group for Halloween 2019! Patients loved the costumes more than the injections and lasers.
